Nurse-Led Culturally Adapted Palliative and End-of-Life Training for Oncology Nurses in Oman (N-PELTP)

March 5, 2026 updated by: Sultan Qaboos University

Effectiveness of a Nurse-Led, Culturally Adapted Palliative and End-of-Life Training Program (N-PELTP) for Oncology Nurses: A Quasi-Experimental Controlled Study

This study evaluated a nurse-led, culturally adapted training program in palliative and end-of-life care (N-PELTP) for oncology nurses in Oman. Nurses in the intervention group received the structured training program, while a comparison group continued usual practice during the same period. Outcomes were assessed using questionnaires completed before and after the intervention to measure palliative care knowledge, attitudes toward caring for dying patients, self-reported palliative care practices, and communication-related outcomes. The goal of the study was to determine whether a culturally adapted educational program can improve oncology nurses' readiness to deliver palliative and end-of-life care.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Palliative and end-of-life care requires skilled nursing communication, symptom management knowledge, and culturally sensitive approaches to care. In many settings, oncology nurses report variable preparation and limited training opportunities in palliative and end-of-life care. This quasi-experimental controlled pretest-posttest study assessed the effectiveness of a nurse-led, culturally adapted palliative and end-of-life training program (N-PELTP) implemented in oncology settings in Oman.

Eligible participants were registered oncology nurses providing direct patient care. The intervention group participated in a structured training program delivered over a defined period, while a comparable control group did not receive the training during the study period. Outcomes were assessed using validated tools at baseline (pre-intervention) and after completion of the intervention (post-intervention). The primary objective was to evaluate change in palliative care knowledge. Secondary objectives included changes in attitudes toward caring for dying patients, self-reported palliative care practices, and communication outcomes.

Study Type

Interventional

Enrollment (Actual)

189

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Oman
      • Muscat, Oman, PC123
        • Royal Hospital
      • Muscat, Oman, PC123
        • Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Registered nurses working in participating oncology/cancer care settings in Oman
  • Providing direct clinical care to patients with cancer
  • Employed at the study site during the study period and expected to remain for the duration of the intervention and follow-up assessments
  • Aged 18 years or older
  • Able to read and understand the study materials and questionnaires
  • Willing to participate and provide informed consent

Exclusion Criteria:

  • Nursing students, interns, or non-registered nursing staff
  • Nurses not providing direct patient care (e.g., administrative/managerial roles without bedside clinical duties)
  • Nurses on extended leave during the intervention or follow-up period (e.g., annual leave, sick leave, maternity leave)
  • Nurses who did not complete the baseline (pre-intervention) assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: N-PELTP Training Program
Participants received the nurse-led, culturally adapted palliative and end-of-life care training program (N-PELTP). Outcomes were assessed before and after the intervention using standardized questionnaires.
Behavioral: N-PELTP Palliative and End-of-Life Training Program
A nurse-led, culturally adapted palliative and end-of-life care education and training program for oncology nurses (N-PELTP). The program was delivered in a structured format over a defined training period and covered core palliative and end-of-life care competencies, including communication and care planning. Outcomes were assessed using standardized questionnaires at baseline (pre-intervention) and after completion of the training (post-intervention
No Intervention: Control (Usual Practice)
Participants continued usual practice during the study period and did not receive the N-PELTP training during the intervention phase. Outcomes were assessed at the same time points as the intervention group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attitude Toward Care of the Dying Score (Frommelt Attitude Toward Care of the Dying Scale, Form B; FATCOD-B)
Time Frame: Baseline (pre-intervention) and 2 weeks post-intervention
Total score on the Frommelt Attitude Toward Care of the Dying Scale, Form B (FATCOD-B), a 30-item instrument rated on a 5-point Likert scale. Total score range: 30 to 150. Higher scores indicate more positive attitudes toward caring for dying patients.
Baseline (pre-intervention) and 2 weeks post-intervention
Palliative and End-of-Life Care Knowledge Score (Palliative and End-of-Life Care Knowledge Questionnaire; PEACE-Q)
Time Frame: Baseline (pre-intervention) and immediately post-intervention
Total score on the Palliative and End-of-Life Care Knowledge Questionnaire (PEACE-Q), a 34-item true/false questionnaire. Total score range: 0 to 34. Higher scores indicate greater palliative/end-of-life care knowledge.
Baseline (pre-intervention) and immediately post-intervention
Palliative Care Self-Reported Practice Score (Palliative Care Self-Reported Practices Scale; PCPS)
Time Frame: Baseline (pre-intervention) and 2 weeks post-intervention
Total score on the Palliative Care Self-Reported Practices Scale (PCPS), an 18-item scale rated from 1 (not at all) to 5 (always). Total score range: 18 to 90. Higher scores indicate more frequent palliative care practices.
Baseline (pre-intervention) and 2 weeks post-intervention
Communication Practice Score (Communication Domain of PCPS)
Time Frame: Baseline (pre-intervention) and 2 weeks post-intervention
Communication practice score derived from the communication domain of the Palliative Care Self-Reported Practices Scale (PCPS). Items are rated from 1 (not at all) to 5 (always). Domain score range: 1 to 5 when calculated as a mean item score. Higher scores indicate more frequent/better communication practices in palliative/end-of-life care contexts.
Baseline (pre-intervention) and 2 weeks post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sultan Qaboos University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2025

Primary Completion (Actual)

July 5, 2025

Study Completion (Actual)

July 5, 2025

Study Registration Dates

First Submitted

March 1, 2026

First Submitted That Met QC Criteria

March 5, 2026

First Posted (Actual)

March 10, 2026

Study Record Updates

Last Update Posted (Actual)

March 10, 2026

Last Update Submitted That Met QC Criteria

March 5, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • N-PELTP-ON-OM-2025 (Other Identifier: Sultan Qaboos University)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared publicly due to participant confidentiality and institutional/ethical restrictions. De-identified summary data may be made available from the corresponding author on reasonable request, subject to ethics approval where applicable.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Palliative Care

Clinical Trials on N-PELTP Palliative and End-of-Life Training Program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe